Tanvex BioPharma Inc TANVF
Tanvex BioPharma Inc. Stock Analysis TANVF
United States Health Care Small Cap Tanvex BioPharma, Inc. operates as clinical stage company, which engages in the research and development, production, and sale of pharmaceutical products. The company employs 201 full-time employees The company went IPO on 2015-08-13. The firm specializes in research, product development, manufacture, and commercialization of biologic and biosimilar drugs. The company has expertise in all areas, such as strain and cell-line development in both microbial and mammalian systems, cell culture, protein purification, process scale-up, drug substance and product manufacturing, and warehousing, sales and distribution. The firm's CDMO services operate under the name Bora Biologics. The Company’s product pipeline includes Neupogen (TX-01), Herceptin (TX-05), Neulasta (TX-04), Avastin (TX-16), Perjeta (TX-52), and others. The company deploys a range of Current Good Manufacturing Practice (cGMP) biologics manufacturing capabilities.
Tanvex BioPharma Inc (TANVF) Chart
Financial Metrics & Statements of Tanvex BioPharma Inc (TANVF)
FAQ's for Tanvex BioPharma Inc (TANVF)
- As of August 2026, Tanvex BioPharma Inc TANVF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tanvex BioPharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Tanvex BioPharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Tanvex BioPharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Tanvex BioPharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Tanvex BioPharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Tanvex BioPharma Inc (TANVF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
